Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2021 Publisher: Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072, ABN: 85 000 612 831
For use as a topical ocular vasoconstrictor.
1 or 2 drops every three to four hours.
In order to minimise systemic absorption of ALBALON eye drops, apply pressure to the tear duct immediately following administration of the drug.
To prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding area with the dropper tip of the bottle.
Not for use in children, unless under medical advice.
ALBALON eye drops can cause peripheral vasoconstriction and severe central nervous depression including hypertension followed by reflex braddycardia and hypotension, marked reduction in body temperature, sweating, drowsiness and coma particularly in susceptible adults and children.
In case of overdosage, flush the affected eye(s) with water or normal saline.
Accidental ingestion (especially in children) may cause marked sedation requiring emergency treatment.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
3 years.
Store below 25°C. Protect from light.
Do not use if solution changes colour or becomes cloudy.
To avoid contamination of the solution, keep container tightly closed.
Do not touch dropper tip to any surface.
Contents are sterile if seal is intact.
ALBALON eye drops solution is supplied in dropper bottles. Each bottle has a fill volume of 15 mL.
Discard unused contents 4 weeks after opening the bottle.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
